Arrieta, O., Lara-Mejía, L., Rios-Garcia, E., Caballé-Perez, E., Cabrera-Miranda, L., Ramos-Ramírez, M., . . . Rosell, R. Alectinib in combination with bevacizumab as first-line treatment in ALK-rearranged non-small cell lung cancer (ALEK-B): A single-arm, phase 2 trial. Nature Portfolio.
Chicago Style (17th ed.) CitationArrieta, Oscar, et al. Alectinib in Combination with Bevacizumab as First-line Treatment in ALK-rearranged Non-small Cell Lung Cancer (ALEK-B): A Single-arm, Phase 2 Trial. Nature Portfolio.
MLA (9th ed.) CitationArrieta, Oscar, et al. Alectinib in Combination with Bevacizumab as First-line Treatment in ALK-rearranged Non-small Cell Lung Cancer (ALEK-B): A Single-arm, Phase 2 Trial. Nature Portfolio.
Warning: These citations may not always be 100% accurate.